India’s Dr Reddy’s Labs posts 11-fold jump in Q4 profit, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Revenue from generic business in North America, the company’s biggest market accounting for almost half of its total sales, jumped 27 per cent to 25.32 billion rupees, on the back of new launches and scaling up of existing products. In India, its revenue from generic drugs business climbed 32 per cent., Revenue from generic business in North America, the company’s biggest market accounting for almost half of its total sales, jumped 27 per cent to 25.32 billion rupees, on the back of new launches and scaling up of existing products. In India, its revenue from generic drugs business climbed 32 per cent., , Read More

Leave a Reply

Your email address will not be published.